theophylline has been researched along with Bronchopulmonary Dysplasia in 8 studies
Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Methylxanthines, including caffeine, theophylline, and aminophylline, work as stimulants of the respiratory drive, and decrease apnea of prematurity, a developmental disorder common in preterm infants." | 9.41 | Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants. ( Bruschettini, M; Marques, KA; Moresco, L; Sjögren, A; Soll, R, 2023) |
| "We studied the effects of orally administered theophylline and diuretics (chlorothiazide and spironolactone) on pulmonary mechanics in 16 infants with bronchopulmonary dysplasia." | 9.06 | Oral theophylline and diuretics improve pulmonary mechanics in infants with bronchopulmonary dysplasia. ( Durand, DJ; Kao, LC; Nickerson, BG; Phillips, BL, 1987) |
| "Theophylline is commonly used to decrease airway resistance in patients with bronchopulmonary dysplasia (BPD)." | 7.67 | Theophylline pharmacokinetics in patients with bronchopulmonary dysplasia. ( Edwards, R; Nahata, MC; Serafini, D, 1989) |
| "Methylxanthines, including caffeine, theophylline, and aminophylline, work as stimulants of the respiratory drive, and decrease apnea of prematurity, a developmental disorder common in preterm infants." | 5.41 | Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants. ( Bruschettini, M; Marques, KA; Moresco, L; Sjögren, A; Soll, R, 2023) |
| "Theophylline use was associated with a significant decrease in PB parameter values only in infants without BPD." | 5.28 | Periodic breathing in preterm infants: influence of bronchopulmonary dysplasia and theophylline. ( Ariagno, RL; Baldwin, RB; Glotzbach, SF; Tansey, PA, 1989) |
| "We studied the effects of orally administered theophylline and diuretics (chlorothiazide and spironolactone) on pulmonary mechanics in 16 infants with bronchopulmonary dysplasia." | 5.06 | Oral theophylline and diuretics improve pulmonary mechanics in infants with bronchopulmonary dysplasia. ( Durand, DJ; Kao, LC; Nickerson, BG; Phillips, BL, 1987) |
| "Theophylline is commonly used to decrease airway resistance in patients with bronchopulmonary dysplasia (BPD)." | 3.67 | Theophylline pharmacokinetics in patients with bronchopulmonary dysplasia. ( Edwards, R; Nahata, MC; Serafini, D, 1989) |
| "Treatment with theophylline, diuretics, and theophylline plus diuretics resulted in a significant improvement in pulmonary mechanics and mechanical power of breathing, but not in VO2." | 2.66 | Improving pulmonary function does not decrease oxygen consumption in infants with bronchopulmonary dysplasia. ( Durand, DJ; Kao, LC; Nickerson, BG, 1988) |
| "Theophylline use was associated with a significant decrease in PB parameter values only in infants without BPD." | 1.28 | Periodic breathing in preterm infants: influence of bronchopulmonary dysplasia and theophylline. ( Ariagno, RL; Baldwin, RB; Glotzbach, SF; Tansey, PA, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Moresco, L | 1 |
| Sjögren, A | 1 |
| Marques, KA | 1 |
| Soll, R | 1 |
| Bruschettini, M | 1 |
| He, H | 1 |
| Chen, F | 1 |
| Ni, W | 1 |
| Li, J | 1 |
| Zhang, Y | 1 |
| Becker, B | 1 |
| Reinhardt, D | 1 |
| Risselmann, K | 1 |
| Morgenroth, K | 1 |
| Kemperdick, H | 1 |
| Lemburg, P | 1 |
| Nahata, MC | 1 |
| Serafini, D | 1 |
| Edwards, R | 1 |
| Glotzbach, SF | 1 |
| Tansey, PA | 1 |
| Baldwin, RB | 1 |
| Ariagno, RL | 1 |
| Kao, LC | 2 |
| Durand, DJ | 2 |
| Phillips, BL | 1 |
| Nickerson, BG | 2 |
| Clancy, RR | 1 |
| Kaplan, KM | 1 |
| Baumgart, S | 1 |
| Rosenberry, KR | 1 |
1 review available for theophylline and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants.
Topics: Aminophylline; Apnea; Birth Weight; Bronchopulmonary Dysplasia; Caffeine; Hearing Loss; Humans; Infa | 2023 |
2 trials available for theophylline and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Oral theophylline and diuretics improve pulmonary mechanics in infants with bronchopulmonary dysplasia.
Topics: Administration, Oral; Bronchopulmonary Dysplasia; Chlorothiazide; Clinical Trials as Topic; Double-B | 1987 |
Improving pulmonary function does not decrease oxygen consumption in infants with bronchopulmonary dysplasia.
Topics: Bronchopulmonary Dysplasia; Diuretics; Double-Blind Method; Humans; Infant, Newborn; Oxygen Consumpt | 1988 |
5 other studies available for theophylline and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Theophylline improves lipopolysaccharide-induced alveolarization arrest through inflammatory regulation.
Topics: Animals; Animals, Newborn; Bronchodilator Agents; Bronchopulmonary Dysplasia; Chemokine CCL3; Chemok | 2014 |
[Pulmonary dysplasia in infancy. Pathogenesis, pneumologic course studies and therapy possibilities].
Topics: Bronchi; Bronchopulmonary Dysplasia; Combined Modality Therapy; Follow-Up Studies; Humans; Hyaline M | 1984 |
Theophylline pharmacokinetics in patients with bronchopulmonary dysplasia.
Topics: Aging; Bronchopulmonary Dysplasia; Humans; Infant; Infant, Newborn; Theophylline | 1989 |
Periodic breathing in preterm infants: influence of bronchopulmonary dysplasia and theophylline.
Topics: Acoustic Impedance Tests; Blood Pressure; Bronchopulmonary Dysplasia; Female; Humans; Infant, Newbor | 1989 |
Neonatal theophylline neurotoxicity.
Topics: Bronchopulmonary Dysplasia; Half-Life; Hepatitis; Humans; Infant; Infant, Newborn; Kinetics; Male; S | 1985 |